Cargando…
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts
Objectives: Systemic sclerosis (SSc) is a connective tissue disorder presenting fibrosis of the skin and internal organs, for which no effective treatments are currently available. Increasing evidence indicates that the P2X7 receptor (P2X7R), a nucleotide-gated ionotropic channel primarily involved...
Autores principales: | Gentile, Daniela, Lazzerini, Pietro E., Gamberucci, Alessandra, Natale, Mariarita, Selvi, Enrico, Vanni, Francesca, Alì, Alessandra, Taddeucci, Paolo, Del-Ry, Silvia, Cabiati, Manuela, Della-Latta, Veronica, Abraham, David J., Morales, Maria A., Fulceri, Rosella, Laghi-Pasini, Franco, Capecchi, Pier L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602350/ https://www.ncbi.nlm.nih.gov/pubmed/28955239 http://dx.doi.org/10.3389/fphar.2017.00638 |
Ejemplares similares
-
Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
por: Lazzerini, Pietro E., et al.
Publicado: (2018) -
Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine
por: Rossi, Marco, et al.
Publicado: (2021) -
Long QT Syndrome: An Emerging Role for Inflammation and Immunity
por: Lazzerini, Pietro Enea, et al.
Publicado: (2015) -
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016) -
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)